<%--
  Created by IntelliJ IDEA.
  User: jthota
  Date: 1/4/2024
  Time: 3:31 PM
  To change this template use File | Settings | File Templates.
--%>
<div class="container">




    <div class="jumbotron text-white rounded" style="background-color: #dceaf9;padding:0">
        <div class="col" align="center">
            <div style="width: 60%" align="center">
<%--            <img class="img-fluid" src="/platform/images/platform-overview.png" />--%>
            <img class="img-fluid" src="/platform/common/images/platform-overview-original-size.png" width="100%"/>
            </div>

        </div>
    </div>

    <div class="row mb-2">
        <div class="col-md-6" style="display: table-cell;" >
            <div class="card  flex-md-row mb-4 box-shadow h-100">
                <div class="card-body d-flex flex-column align-items-start">
                    <strong class="d-inline-block mb-2 text-primary">SCGE Program Background</strong>
                    <%--                    <h3 class="mb-0">--%>
                    <%--&lt;%&ndash;                        <a class="text-dark" href="#">SCGE Program Background</a>&ndash;%&gt;--%>
                    <%--                    </h3>--%>
                    <%--                    <div class="mb-1 text-muted"></div>--%>
                    <%--                    <p class="card-text mb-auto"></p>--%>
                    <ul>
                        <li>Genome Editing allows precise corrections to be made in patients DNA and RNA</li>
                        <li>CRISPR-Cas9 catalyzed development of experimental genomed editing therapeutics.</li>
                        <li>Thousands of genetic diseases are amenable to targeted in vivo genome editing approaches</li>

                    </ul>

                </div>
                <%--                <img class="card-img-right flex-auto" src="/platform/images/body-image.png" alt="SCGE Program Background">--%>
            </div>
        </div>
        <div class="col-md-6" style="display: table-cell;">
            <div class="card flex-md-row mb-4 box-shadow h-100">
                <div class="card-body d-flex flex-column align-items-start">
                    <strong class="d-inline-block mb-2 text-success">SCGE Phase 1</strong>
                    <%--                    <h3 class="mb-0">--%>
                    <%--&lt;%&ndash;                        <a class="text-dark" href="#">SCGE Phase I</a>&ndash;%&gt;--%>
                    <%--                    </h3>--%>
                    <%--                    <div class="mb-1 text-muted">Nov 11</div>--%>

                    <p class="card-text mb-auto">Gaps and Opportunities from 2017 Common Fund Planning Workshop</p>
                    <ul>
                        <li>Improved animal models to detect editing</li>
                        <li>Human Cell Systems for measuring adverse events</li>
                        <li>Delivery Systems for in vivo targeting</li>
                        <li>Methods to track edited cells in vivo.</li>
                        <li>Safer and more effective editors</li>
                    </ul>
                    <p class="card-text mb-auto">SCGE Phase I addressed these gaps.</p>

                    <a href="https://scge.mcw.edu/toolkit">SCGE Toolkit</a>
                    <%--                    <a href="#">Continue reading</a>--%>
                </div>
                <%--                <img class="card-img-right flex-auto d-none d-md-block" data-src="holder.js/200x250?theme=thumb" alt="Card image cap">--%>
            </div>
        </div>
    </div>
</div>

<main role="main" class="container">
    <div class="row">
        <div class="col-md-8 blog-main">
            <h3 class="pb-3 mb-4 font-italic border-bottom">
                SCGE Platform Projects
            </h3>

            <div class="blog-post">
                <h4 class="blog-post-title">Technologies and Assays for Therapeutic Genome Editing INDs (RFA-RM-22-014)</h4>
                <hr>
                <p><a href="">Utility of Human Organoids for Safety and Efficiency Evaluations of Genome Editing Therapeutics.</a><br>
                    <span class="blog-post-meta">PI: Freedman, Benjamin University of Washington</span></p>

                <p><a href="">A Modality-Agnostic Potency Assay Enabling Both Ex Vivo and In Vivo Genome Editing Therapeutics for Sickle Cell Disease</a><br>
                    <span class="blog-post-meta">PI: Giannikopoulos, Petros University of California Berkeley</span></p>

            </div>

            <div class="blog-post">
                <h4 class="blog-post-title">IND-enabling Studies of Somatic Genome Editing Therapeutic Leads (RFA-RM-22-015)</h4>
                <hr>
                <p><a href="">Utility of Human Organoids for Safety and Efficiency Evaluations of Genome Editing Therapeutics.</a><br>
                    <span class="blog-post-meta">PI: Freedman, Benjamin University of Washington</span></p>

                <p><a href="">A Modality-Agnostic Potency Assay Enabling Both Ex Vivo and In Vivo Genome Editing Therapeutics for Sickle Cell Disease</a><br>
                    <span class="blog-post-meta">PI: Giannikopoulos, Petros University of California Berkeley</span></p>

            </div>

            <div class="blog-post">
                <h4 class="blog-post-title">Platform Clinical Trials of Genome Editors in Multiple Diseases (RFA-RM-22-016)</h4>
                <hr>
                <p><a href="">Utility of Human Organoids for Safety and Efficiency Evaluations of Genome Editing Therapeutics.</a><br>
                    <span class="blog-post-meta">PI: Freedman, Benjamin University of Washington</span></p>

                <p><a href="">A Modality-Agnostic Potency Assay Enabling Both Ex Vivo and In Vivo Genome Editing Therapeutics for Sickle Cell Disease</a><br>
                    <span class="blog-post-meta">PI: Giannikopoulos, Petros University of California Berkeley</span></p>

            </div>
            <br>
            <br>
        </div><!-- /.blog-main -->

        <aside class="col-md-4 blog-sidebar">
            <div class="p-3 mb-3 bg-light rounded">
                <h4 class="font-italic">About</h4>
                <p class="mb-0">The National Institutes of Health (NIH) has awarded over $140 million to help accelerate genome editing approaches from the lab to the clinic. The newly funded projects build upon the work performed though the Somatic Cell Genome Editing (SCGE) Program over the past five years and will focus on translating safe and effective genome editing therapeutics into the clinic.</p>
            </div>

            <div class="p-3">
                <h4 class="font-italic">Resources/links</h4>
                <ol class="list-unstyled mb-0">
                    <li><a href="https://www.fda.gov/drugs/investigational-new-drug-ind-application/ind-forms-and-instructions">IND Forms and Instructions</a></li>
                    <li><a href="https://www.fda.gov/drugs/types-applications/investigational-new-drug-ind-application#FDA%20Guidances%20for%20Investigational%20New%20Drugs">Guidance Documents for INDs</a></li>

                </ol>
            </div>

            <div class="p-3">
                <h4 class="font-italic">Follow us on</h4>
                <ol class="list-unstyled">
                    <li><i class="fa-brands fa-github"></i>&nbsp;<a href="#">GitHub</a></li>
                    <li><img src="/platform/common/images/logo-black.png" width="15" height="15">&nbsp;<a href="#">Twitter</a></li>
                    <li><i class="fa-brands fa-facebook-f"></i>&nbsp;<a href="#">Facebook</a></li>
                </ol>
            </div>
        </aside><!-- /.blog-sidebar -->

    </div><!-- /.row -->

</main><!-- /.container -->
